Company page

Contrafect Corporation

Contrafect Corporation, trading under the ticker CFRXQ, is a public company based in the United States with a market capitalization of approximately $10.7 million. The company focuses on developing innovative therapies for serious bacterial infections. Its commitment to advancing healthcare solutions positions it as a notable player in the biotechnology sector.